Literature DB >> 26638131

[Accelerated partial breast irradiation using interstitial multicatheter brachytherapy: A valid treatment option for breast cancer patients with a low-risk profile?].

David Krug1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26638131     DOI： 10.1007/s00066-015-0932-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  10 in total

1.  Letters Regarding the TARGIT-A Trial: The Editor's Introduction.

Authors:  Anthony Zietman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-07-14       Impact factor: 7.038

2.  Non-inferiority trials: why oncologists must remain wary.

Authors:  Mauricio Burotto; Vinay Prasad; Tito Fojo
Journal:  Lancet Oncol       Date:  2015-04       Impact factor: 41.316

3.  Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI.

Authors:  Frank Vicini; Chirag Shah; J Ben Wilkinson; Martin Keisch; Peter Beitsch; Maureen Lyden
Journal:  Ann Surg Oncol       Date:  2012-09-29       Impact factor: 5.344

4.  Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy.

Authors:  Ivo A Olivotto; Timothy J Whelan; Sameer Parpia; Do-Hoon Kim; Tanya Berrang; Pauline T Truong; Iwa Kong; Brandy Cochrane; Alan Nichol; Isabelle Roy; Isabelle Germain; Mohamed Akra; Melanie Reed; Anthony Fyles; Theresa Trotter; Francisco Perera; Wayne Beckham; Mark N Levine; Jim A Julian
Journal:  J Clin Oncol       Date:  2013-07-08       Impact factor: 44.544

5.  Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial.

Authors:  Csaba Polgár; János Fodor; Tibor Major; Zoltán Sulyok; Miklós Kásler
Journal:  Radiother Oncol       Date:  2013-06-03       Impact factor: 6.280

6.  Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial.

Authors:  Lorenzo Livi; Icro Meattini; Livia Marrazzo; Gabriele Simontacchi; Stefania Pallotta; Calogero Saieva; Fabiola Paiar; Vieri Scotti; Carla De Luca Cardillo; Paolo Bastiani; Lorenzo Orzalesi; Donato Casella; Luis Sanchez; Jacopo Nori; Massimiliano Fambrini; Simonetta Bianchi
Journal:  Eur J Cancer       Date:  2015-01-17       Impact factor: 9.162

7.  Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.

Authors:  Umberto Veronesi; Roberto Orecchia; Patrick Maisonneuve; Giuseppe Viale; Nicole Rotmensz; Claudia Sangalli; Alberto Luini; Paolo Veronesi; Viviana Galimberti; Stefano Zurrida; Maria Cristina Leonardi; Roberta Lazzari; Federica Cattani; Oreste Gentilini; Mattia Intra; Pietro Caldarella; Bettina Ballardini
Journal:  Lancet Oncol       Date:  2013-11-11       Impact factor: 41.316

8.  5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.

Authors:  Vratislav Strnad; Oliver J Ott; Guido Hildebrandt; Daniela Kauer-Dorner; Hellen Knauerhase; Tibor Major; Jaroslaw Lyczek; Jose Luis Guinot; Jürgen Dunst; Cristina Gutierrez Miguelez; Pavel Slampa; Michael Allgäuer; Kristina Lössl; Bülent Polat; György Kovács; Arnt-René Fischedick; Thomas G Wendt; Rainer Fietkau; Marion Hindemith; Alexandra Resch; Anna Kulik; Leo Arribas; Peter Niehoff; Fernando Guedea; Annika Schlamann; Richard Pötter; Christine Gall; Martina Malzer; Wolfgang Uter; Csaba Polgár
Journal:  Lancet       Date:  2015-10-19       Impact factor: 79.321

9.  Pride, Prejudice, or Science: Attitudes Towards the Results of the TARGIT-A Trial of Targeted Intraoperative Radiation Therapy for Breast Cancer.

Authors:  Jayant S Vaidya; Max Bulsara; Frederik Wenz; David Joseph; Christobel Saunders; Samuele Massarut; Henrik Flyger; Wolfgang Eiermann; Michael Alvarado; Laura Esserman; Mary Falzon; Chris Brew-Graves; Ingrid Potyka; Jeffrey S Tobias; Michael Baum
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-08       Impact factor: 7.038

10.  Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.

Authors:  Jayant S Vaidya; Frederik Wenz; Max Bulsara; Jeffrey S Tobias; David J Joseph; Mohammed Keshtgar; Henrik L Flyger; Samuele Massarut; Michael Alvarado; Christobel Saunders; Wolfgang Eiermann; Marinos Metaxas; Elena Sperk; Marc Sütterlin; Douglas Brown; Laura Esserman; Mario Roncadin; Alastair Thompson; John A Dewar; Helle M R Holtveg; Steffi Pigorsch; Mary Falzon; Eleanor Harris; April Matthews; Chris Brew-Graves; Ingrid Potyka; Tammy Corica; Norman R Williams; Michael Baum
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321
  10 in total
  3 in total

1.  Cosmetic changes following surgery and accelerated partial breast irradiation using HDR interstitial brachytherapy : Evaluation by a multidisciplinary/multigender committee.

Authors:  Tamer Soror; György Kovács; Nina Seibold; Corinna Melchert; Kristin Baumann; Eike Wenzel; Suzana Stojanovic-Rundic
Journal:  Strahlenther Onkol       Date:  2017-01-02       Impact factor: 3.621

2.  Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy.

Authors:  Hans-Christian Kolberg; Gyoergy Loevey; Leyla Akpolat-Basci; Miltiades Stephanou; Peter A Fasching; Michael Untch; Cornelia Liedtke; Max Bulsara; Jayant S Vaidya
Journal:  Strahlenther Onkol       Date:  2016-11-17       Impact factor: 3.621

3.  Implementation of image-guided intensity-modulated accelerated partial breast irradiation : Three-year results of a phase II clinical study.

Authors:  Norbert Mészáros; Tibor Major; Gábor Stelczer; Zoltán Zaka; Emőke Mózsa; Dávid Pukancsik; Zoltán Takácsi-Nagy; János Fodor; Csaba Polgár
Journal:  Strahlenther Onkol       Date:  2016-11-21       Impact factor: 3.621
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.